Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending November 19, 2017
Azacitidine in Lower-Risk MDS Shows Promise, Oncologist; ePub 2017 Nov 8; Komrokji, et al
Clostridium Difficile Infection in People with MDS, World J Clin Oncol; 2017 Oct 10; Shaht, et al
Survival in Azacitidine-Treated Patients Assessed, Leuk Res; 2017 Oct 27; Sébert, Komrokji et al
Use This to Evaluate MRD Prior to Allo-SCT, Leuk Res; 2017 Dec; Candoni, De Marchi, et al
Detecting Minimal Residual Disease in AML, Curr Hematol Malig Rep; ePub 2017 Nov 2; Zhou, et al
Must reads for theWeek ending November 12, 2017
Long-Term Survival with Ruxolitinib Evaluated, J Hematol Oncol; 2017 Sep 29; Verstovsek, et al
Ruxolitininb Compared with Momelotinib for MF, J Clin Oncol; ePub 2017 Sep 20; Mesa, et al
Hematologic Malignancies of the Breast Studied, South Med J; 2017 Oct; Alsadi, Lin, Alnajar, et al
Autoimmune Myelofibrosis and Cytopenia Development, Acta Haematol; 2017 Sep 2; Piatek, et al
Using MPN Patient Reported Outcomes in Practice, Curr Hematol Malig Rep; ePub 2017 Sep 23; Geyer, et al
Must reads for theWeek ending November 5, 2017
Azacitidine Alone Offers Superior 1-Year Survival, Haematologica; ePub 2017 Oct 26; Medeiros, et al
Low-Dose HMAs for Lower-Risk MDS/MPNs Evaluated, Blood; 2017 Sept 28; Jabbour, Short, et al
Prognostic Impact of Therapy-Related CMML, Am J Hematol; ePub 2017 Oct 11; Patnaik, et al
Molecular Predictive and Prognostic Factors in AML, Leuk Lymphoma; ePub 2017 Nov 2; McCurdy, et al
A More Personalized Approach to AML, Clin Lymphoma Myeloma Leuk; ePub 2017 Oct 19; Sweet, et al
Must reads for theWeek ending October 29, 2017
Exercise Intolerance in Patients with HFpEF, Circulation; ePub 2017 Oct 9; Houstis, et al
Lower Heart Discharge Rates in Patients with HFpEF, J Am Coll Cardiol; 2017 Oct; Lam, Dooley, et al
HF Medication Use & Adherence After LVAD , J Am Heart Assoc; ePub 2017 Oct 3; Tan, et al
Intravascular Volume in Patients with Class I & II HF, J Card Fail; ePub 2017 Oct 2; Miller, et al
Implementation of Patient-Reported Outcomes in HF, J Card Fail; ePub 2017 Oct 2; Stehlik, et al
Must reads for theWeek ending October 22, 2017
LAMA + LABA for Patients with Stable COPD, JAMA; 2017 Oct 3; Horita, Nagashima, et al
Assessing CCTA for Patients with Suspected CAD, JAMA Intern Med; ePub 2017 Oct 2; Foy, et al
Rivaroxaban + Aspirin for CV Prevention, N Engl J Med; 2017 Oct 5; Eikelboom, et al
Exenatide Effects in Patients with Parkinson Disease, Lancet; 2017 Oct 7; Athauda, Maclagan, et al
FDA Approves Fast-Acting Mealtime Insulin, Novo Nordisk news release; 2017 Sep 29